
Food and Drug Administration (FDA) to Hold Hearing on BENLYSTA® on November 16th
On November 16, 2010, the Food and Drug Administration (FDA) will hold a hearing to discuss the application to approve BENLYSTA® (belimumab) as a treatment to reduce disease activity in adults with active, autoantibody-positive lupus. If approved, BENLYSTA® will be the first drug to be specif
[ 4 comments ] | [ read more ]